{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:40:25Z","timestamp":1792190425091,"version":"4.4.0"},"reference-count":211,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lpm.2023.104174","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T20:57:33Z","timestamp":1696021053000},"page":"104174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Bronchiectasis"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-7027","authenticated-orcid":false,"given":"Miguel","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0001","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0002","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2023.104174_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12931-022-02023-8","article-title":"Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013\u20132017: a nationwide population-based cohort study","volume":"23","author":"Feng","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.lpm.2023.104174_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2023.104174_bib0006","article-title":"Nat Rev Dis Primers","volume":"4","author":"Chalmers","year":"2018"},{"issue":"10150","key":"10.1016\/j.lpm.2023.104174_bib0007","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2023.104174_bib0008","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/thx.2003.008037","article-title":"Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis","volume":"59","author":"Watt","year":"2004","journal-title":"Airway Biol Thorax"},{"key":"10.1016\/j.lpm.2023.104174_bib0009","unstructured":"Rogers G.B., Van Der Gast C.J., Cuthbertson L., Thomson S.K., Bruce K.D., Martin M.L., et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Available from: http:\/\/thorax.bmj.com\/"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0041-1730891","article-title":"Pathophysiology of bronchiectasis","volume":"42","author":"Keir","year":"2021","journal-title":"Semin Respir Crit Care Med."},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0011","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J Cell Biol"},{"issue":"8","key":"10.1016\/j.lpm.2023.104174_bib0012","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lpm.2023.104174_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115996","article-title":"Protease\u2013antiprotease imbalance in bronchiectasis","volume":"22","author":"Oriano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.lpm.2023.104174_bib0014","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.166.11.6847","article-title":"Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases 1","volume":"166","author":"Fadok","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI0213572","article-title":"Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis","volume":"109","author":"Vandivier","year":"2002","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2012.09.011","article-title":"Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis","volume":"55","author":"Chalmers","year":"2013","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0017","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2222.2000.00804.x","article-title":"Eosinophils are a feature of upper and lower airway pathology in non- atopic asthma, irrespective of the presence of rhinitis","volume":"30","author":"Gaga","year":"2000","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"10.1016\/j.lpm.2023.104174_bib0018","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of eosinophilic bronchiectasis a European multicohort study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.lpm.2023.104174_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070772","article-title":"T2-high endotype and response to biological treatments in patients with bronchiectasis","volume":"9","author":"Oriano","year":"2021","journal-title":"Biomedicines"},{"issue":"Suppl 3","key":"10.1016\/j.lpm.2023.104174_bib0020","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1513\/AnnalsATS.201802-128AW","article-title":"Airway epithelial differentiation and mucociliary clearance","volume":"15","author":"Whitsett","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0021","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00097014","article-title":"Cyanide levels found in infected cystic fibrosis sputum inhibit airway ciliary function","volume":"44","author":"Nair","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0022","doi-asserted-by":"crossref","DOI":"10.1165\/ajrcmb\/4.1.26","article-title":"Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium","volume":"4","author":"Amitani","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0023","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non-cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.lpm.2023.104174_bib0024","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/thx.53.8.685","article-title":"Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis","volume":"53","author":"Gaga","year":"1998","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gene.2015.12.061","article-title":"Epithelial sodium channel (ENaC) family: phylogeny, structure-function, tissue distribution, and associated inherited diseases","volume":"579","author":"Hanukoglu","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.lpm.2023.104174_bib0026","doi-asserted-by":"crossref","DOI":"10.4103\/1947-2714.141620","article-title":"The clinical manifestations, diagnosis and management of Williams-Campbell syndrome","volume":"6","author":"Noriega Aldave","year":"2014","journal-title":"N Am J Med Sci"},{"issue":"10","key":"10.1016\/j.lpm.2023.104174_bib0027","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201210-1937OC","article-title":"Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation","volume":"187","author":"Tunney","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2023.104174_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/706376","article-title":"The lung immune response to nontypeable haemophilus influenzae (lung immunity to nthi)","volume":"2015","author":"King","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.lpm.2023.104174_bib0029","first-page":"165","article-title":"Interaction of Haemophilus influenzae with Mucus, Cilia, and Respiratory Epithelium","author":"Wilson","year":"1992","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1774-x","article-title":"Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study","volume":"16","author":"M\u00e1iz","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lpm.2023.104174_bib0031","doi-asserted-by":"crossref","DOI":"10.1159\/000518328","article-title":"Prevalence and clinical characteristics of nontuberculous mycobacteria in patients with bronchiectasis: a systematic review and meta-analysis","volume":"100","author":"Zhu","year":"2021","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0032","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-018-0636-2","article-title":"Viruses in bronchiectasis: a pilot study to explore the presence of community acquired respiratory viruses in stable patients and during acute exacerbations","volume":"18","author":"Mitchell","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.lpm.2023.104174_bib0033","doi-asserted-by":"crossref","DOI":"10.1007\/s11046-021-00539-z","article-title":"Respiratory mycoses in COPD and bronchiectasis","volume":"186","author":"Tiew","year":"2021","journal-title":"Mycopathologia"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0034","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/S2666-5247(21)00300-1","article-title":"Prevalence and subtyping of biofilms present in bronchoalveolar lavage from children with protracted bacterial bronchitis or non-cystic fibrosis bronchiectasis: a cross-sectional study","volume":"3","author":"Marsh","year":"2022","journal-title":"Lancet Microbe"},{"issue":"11","key":"10.1016\/j.lpm.2023.104174_bib0035","first-page":"1602","article-title":"A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0036","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-3437","article-title":"Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention","volume":"11","author":"Choi","year":"2023","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0037","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0038","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0119-2021","article-title":"Precision medicine in bronchiectasis","volume":"17","author":"Pembridge","year":"2021","journal-title":"Breathe"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0039","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01289-2017","article-title":"Standardised classification of the aetiology of bronchiectasis using an objective algorithm","volume":"50","author":"Ara\u00fajo","year":"2017","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.lpm.2023.104174_bib0040","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/resp.12832","article-title":"Aetiology of bronchiectasis in adults: a systematic literature review","volume":"21","author":"Gao","year":"2016","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0041","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1378\/chest.10-1758","article-title":"Factors associated with bronchiectasis in patients with COPD","volume":"140","author":"Mart\u00ednez-Garc\u00eda","year":"2011","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.lpm.2023.104174_bib0042","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.arbres.2021.08.001","article-title":"Bronchiectasis and eosinophils","volume":"57","author":"Mart\u00ednez-Garc\u00eda","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.lpm.2023.104174_bib0043","series-title":"Multimorbidity in bronchiectasis: a systematic scoping review. Vol. 9","author":"Marsland","year":"2023"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0044","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1183\/20734735.007516","article-title":"Global impact of bronchiectasis and cystic fibrosis","volume":"12","author":"Redondo","year":"2016","journal-title":"Breathe"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccm.2021.11.008","article-title":"Diagnosis of primary ciliary dyskinesia","volume":"43","author":"Goutaki","year":"2022","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0046","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.arbres.2022.12.001","article-title":"Primary ciliary dyskinesia and bronchiectasis: new data and future challenges","volume":"59","author":"Pioch","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.lpm.2023.104174_bib0047","author":"Cheslock","year":"2022","journal-title":"Yellow nail syndrome"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0048","first-page":"103","article-title":"Tajamul. Swyer-James-MacLeod syndrome","volume":"22","author":"Kamili","year":"2022","journal-title":"J Int Med Sci Acad"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0049","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.rmed.2013.08.042","article-title":"Mounier-Kuhn syndrome or congenital tracheobronchomegaly: a literature review","volume":"107","author":"Krustins","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.lpm.2023.104174_bib0050","author":"Shaikh","year":"2022","journal-title":"Right middle lobe syndrome"},{"key":"10.1016\/j.lpm.2023.104174_bib0051","series-title":"Bronchial atresia","author":"Hutchison","year":"2022"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0052","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/crj.13294","article-title":"The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap","volume":"15","author":"Tiew","year":"2021","journal-title":"Clin Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccm.2021.11.002","article-title":"Microbiology and the microbiome in bronchiectasis","volume":"43","author":"Mac Aog\u00e1in","year":"2022","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0054","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1183\/09031936.00119114","article-title":"Management of bronchiectasis in adults","volume":"45","author":"Chalmers","year":"2015","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.tim.2013.03.004","article-title":"Interpreting infective microbiota: the importance of an ecological perspective","volume":"21","author":"Rogers","year":"2013","journal-title":"Trends Microbiol"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0056","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: a long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0057","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-020-00667-6","article-title":"Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment","volume":"27","author":"Gopalaswamy","year":"2020","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0058","article-title":"Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK","volume":"7","author":"Lipman","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0059","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-84537-7","article-title":"Geographical distribution and regional differences in 532 clinical isolates of rapidly growing mycobacterial species in Japan","volume":"11","author":"Kamada","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0061","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-020-1080-7","article-title":"Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"S2","key":"10.1016\/j.lpm.2023.104174_bib0062","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jpids\/piac036","article-title":"Exploring the CF lung microbiome \u2022 JPIDS 2022:11 (Suppl 2) \u2022 S13 exploring the cystic fibrosis lung microbiome: making the most of a sticky situation","volume":"11","author":"Thornton","year":"2022","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"153","key":"10.1016\/j.lpm.2023.104174_bib0063","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0048-2019","article-title":"The microbiome in bronchiectasis","volume":"28","author":"Richardson","year":"2019","journal-title":"Eur Respir Rev"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170622","article-title":"Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients","volume":"12","author":"Cox","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/resp.13653","article-title":"Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis","volume":"25","author":"O'Neill","year":"2020","journal-title":"Respirology"},{"issue":"164","key":"10.1016\/j.lpm.2023.104174_bib0066","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0259-2021","article-title":"Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome","volume":"31","author":"Pailhori\u00e8s","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0067","first-page":"688","article-title":"Integrative microbiomics in bronchiectasis exacerbations","volume":"27","author":"Mac Aog\u00e1in","year":"2021","journal-title":"Nature Medicine 2021"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0068","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrmicro2259","article-title":"Bacterial competition: surviving and thriving in the microbial jungle","volume":"8","author":"Hibbing","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"10.1016\/j.lpm.2023.104174_bib0069","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","article-title":"The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study","volume":"9","author":"Dicker","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance","volume":"109","author":"McDonnell","year":"2015","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.lpm.2023.104174_bib0071","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u2018frequent exacerbator phenotype\u2019 in bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0072","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ismej.2013.232","article-title":"Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by Pseudomonas aeruginosa","volume":"8","author":"Venkataraman","year":"2014","journal-title":"ISME J"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0073","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1183\/13993003.01293-2021","article-title":"Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease","volume":"59","author":"Rigauts","year":"2022","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0074","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.lpm.2023.104174_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9071357","article-title":"Virome in the lungs: the role of anelloviruses in childhood respiratory diseases","volume":"9","author":"Dodi","year":"2021","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0076","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1099\/jgv.0.000627","article-title":"Viral-bacterial interactions in the respiratory tract","volume":"97","author":"Bellinghausen","year":"2016","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0077","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1378\/chest.14-1961","article-title":"The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study","volume":"147","author":"Gao","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0078","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcf.2012.04.006","article-title":"Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis","volume":"11","author":"Asner","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2023.104174_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.914498","article-title":"An overview of human T-lymphotropic virus type 1 lung injury","volume":"13","author":"Dias","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10040810","article-title":"The human mycobiome in chronic respiratory diseases: current situation and future perspectives","volume":"10","author":"de Dios Caballero","year":"2022","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0081","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000381289","article-title":"Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis","volume":"89","author":"M\u00e1iz","year":"2015","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0082","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60015-4","article-title":"Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis","volume":"10","author":"Soret","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036313","article-title":"The airway microbiota in cystic fibrosis: a complex fungal and bacterial community\u2013implications for therapeutic management","volume":"7","author":"Delhaes","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2023.104174_bib0084","article-title":"Aspergillus-associated airway disease, inflammation, and the innate immune response","volume":"14","author":"Chotirmall","year":"2013","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcf.2020.05.013","article-title":"The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"20","author":"Cuthbertson","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0086","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00219-16","article-title":"Volatile compounds emitted by Pseudomonas aeruginosa stimulate growth of the fungal pathogen Aspergillus fumigatus","volume":"7","author":"Briard","year":"2016","journal-title":"MBio"},{"issue":"10","key":"10.1016\/j.lpm.2023.104174_bib0087","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20194514","article-title":"Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis","volume":"40","author":"He","year":"2020","journal-title":"Biosci Rep"},{"issue":"sup1","key":"10.1016\/j.lpm.2023.104174_bib0088","doi-asserted-by":"crossref","DOI":"10.1080\/15412555.2017.1286171","article-title":"Bronchiectasis: phenotyping a Complex Disease","volume":"14","author":"Chalmers","year":"2017","journal-title":"COPD"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0089","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1535370220972324","article-title":"The clinical phenotype of bronchiectasis and its clinical guiding implications","volume":"246","author":"Gao","year":"2021","journal-title":"Exp Biol Med"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0090","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.01899-2015","article-title":"Clinical phenotypes in adult patients with bronchiectasis","volume":"47","author":"Aliberti","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0091","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0092","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"Mart\u00ednez-Garc\u00eda","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2023.104174_bib0093","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: the E-FACED score","volume":"12","author":"Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.lpm.2023.104174_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.rppnen.2017.08.009","article-title":"The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis","author":"Costa","year":"2018","journal-title":"Pulmonology"},{"issue":"22","key":"10.1016\/j.lpm.2023.104174_bib0095","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the dpp-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0096","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2022.07.007","article-title":"A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection","volume":"163","author":"Guan","year":"2023","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0097","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0098","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/thx.5.3.233","article-title":"Reduction in bronchial subdivision in bronchiectasis","volume":"5","author":"Reid","year":"1950","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0099","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.179.3.2027992","article-title":"Cystic fibrosis: scoring system with thin-section CT","volume":"179","author":"Bhalla","year":"1991","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpeds.2004.02.038","article-title":"High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests","volume":"145","author":"Brody","year":"2004","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0101","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.chest.2017.11.033","article-title":"The BRICS (Bronchiectasis Radiologically Indexed CT Score): a multicenter study score for use in idiopathic and postinfective bronchiectasis","volume":"153","author":"Bedi","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000448557","article-title":"The importance of phenotyping bronchiectasis","volume":"92","author":"Battaglia","year":"2016","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0103","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MCP.0000000000000569","article-title":"Bronchiectasis phenotypes","volume":"25","author":"Chang-Macchiu","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.lpm.2023.104174_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.pulmoe.2023.03.004","article-title":"Endotypes in bronchiectasis: moving towards precision medicine. A narrative review","author":"Martins","year":"2023","journal-title":"Pulmonology"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5588\/ijtld.15.0500","article-title":"Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics","volume":"20","author":"Guan","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"10.1016\/j.lpm.2023.104174_bib0106","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1513\/AnnalsATS.201510-678OC","article-title":"The multiple faces of non-cystic fibrosis bronchiectasis. a cluster analysis approach","volume":"13","author":"Mart\u00ednez-Gar\u0107ia","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0107","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.chest.2020.11.011","article-title":"A cluster analysis of bronchiectasis patients based on the airway immune profile","volume":"159","author":"Perea","year":"2021","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0108","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00303-2019","article-title":"A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation","volume":"53","author":"Shoemark","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0109","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1055\/s-0041-1730892","article-title":"Diagnosis and initial investigation of bronchiectasis","volume":"42","author":"Amati","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104174_bib0110","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0111","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4046\/trd.2021.0136","article-title":"Developing a diagnostic bundle for bronchiectasis in South Korea: a modified delphi consensus study","volume":"85","author":"Choi","year":"2022","journal-title":"Tuberc Respir Dis"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0113","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1055\/s-0041-1730922","article-title":"Airway clearance and mucoactive therapies","volume":"42","author":"Mu\u00f1oz Castro","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.lpm.2023.104174_bib0115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011699","article-title":"Airway clearance techniques for bronchiectasis","volume":"2015","author":"Lee","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"10.1016\/j.lpm.2023.104174_bib0117","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247323","article-title":"Long-term domiciliary high-flow nasal therapy in patients with bronchiectasis: a preliminary retrospective observational case-control study","volume":"11","author":"Crimi","year":"2022","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.lpm.2023.104174_bib0118","article-title":"Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis","volume":"9","author":"Lee","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0114","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/resp.13459","article-title":"Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis","volume":"24","author":"O'Neill","year":"2019","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0119","article-title":"Mucolytics for bronchiectasis","volume":"2014","author":"Wilkinson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.lpm.2023.104174_bib0120","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","volume":"2015","author":"Welsh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2023.104174_bib0121","series-title":"Mucolytic medications","author":"Gupta","year":"2022"},{"issue":"116","key":"10.1016\/j.lpm.2023.104174_bib0122","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09059180.00003510","article-title":"Mucoactive drugs","volume":"19","author":"Balsamo","year":"2010","journal-title":"Eur Respir Rev"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0123","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"Nicolson","year":"2012","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.lpm.2023.104174_bib0124","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/ppul.20909","article-title":"Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis","volume":"43","author":"Dellon","year":"2008","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.lpm.2023.104174_bib0126","article-title":"Nebulised hypertonic saline for cystic fibrosis","volume":"9","author":"Wark","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2023.104174_bib0127","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619866102","article-title":"Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review","volume":"13","author":"M\u00e1iz Carro","year":"2019","journal-title":"Ther Adv Respir Dis"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0128","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of hypertonic saline solutions on sputum expectoration and their safety profile in patients with bronchiectasis: a randomized crossover trial","volume":"31","author":"Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/13543784.11.1.15","article-title":"Mucoactive drugs for asthma and COPD: any place in therapy?","volume":"11","author":"Rogers","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"issue":"1\u20133","key":"10.1016\/j.lpm.2023.104174_bib0131","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejphar.2004.10.007","article-title":"Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys)","volume":"505","author":"Carpagnano","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"23","key":"10.1016\/j.lpm.2023.104174_bib0132","first-page":"4030","article-title":"Effects of a long-term use of carbocysteine on frequency and duration of exacerbations in patients with bronchiectasis. Open access maced","volume":"7","author":"Minov","year":"2019","journal-title":"J Med Sci"},{"issue":"SUPPL. 1","key":"10.1016\/j.lpm.2023.104174_bib0133","article-title":"Erdosteine: antitussive and anti-inflammatory effects","volume":"186","author":"Negro","year":"2008","journal-title":"Lung"},{"issue":"17","key":"10.1016\/j.lpm.2023.104174_bib0134","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s40265-020-01412-x","article-title":"Multifaceted beneficial effects of erdosteine: more than a mucolytic agent","volume":"80","author":"Cazzola","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.phrs.2006.12.006","article-title":"An overview of erdosteine antioxidant activity in experimental research","volume":"55","author":"Moretti","year":"2007","journal-title":"Pharmacol Res"},{"issue":"9","key":"10.1016\/j.lpm.2023.104174_bib0136","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.clinthera.2007.09.003","article-title":"Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study","volume":"29","author":"Crisafulli","year":"2007","journal-title":"Clin Ther"},{"issue":"3\u20134","key":"10.1016\/j.lpm.2023.104174_bib0137","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000195910","article-title":"Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multicenter study versus placebo","volume":"58","author":"Olivieri","year":"1991","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0138","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","article-title":"Mucolytics in cystic fibrosis","volume":"8","author":"Henke","year":"2007","journal-title":"Paediatr Respir Rev"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0139","article-title":"Dornase alfa for cystic fibrosis","volume":"3","author":"Yang","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0140","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0141","article-title":"Inhaled mannitol for cystic fibrosis","volume":"2020","author":"Nevitt","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0142","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial","volume":"69","author":"Bilton","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2023.104174_bib0112","article-title":"Effect of exercise-based pulmonary rehabilitation in patients with bronchiectasis: a meta-analysis","volume":"81","author":"Yang","year":"2022","journal-title":"Respir Med Res"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0116","article-title":"Telerehabilitation for chronic respiratory disease","volume":"1","author":"Cox","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ccm.2021.11.009","article-title":"Antibiotic management in bronchiectasis","volume":"43","author":"Haworth","year":"2022","journal-title":"Clin Chest Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0144","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2023.104174_bib0146","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rmed.2016.06.007","article-title":"Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"117","author":"Wilson","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.lpm.2023.104174_bib0147","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102095","article-title":"The immunomodulatory effects of macrolide antibiotics in respiratory disease","volume":"71","author":"Pollock","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0148","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"issue":"9842","key":"10.1016\/j.lpm.2023.104174_bib0149","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0150","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.lpm.2023.104174_bib0151","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.lpm.2023.104174_bib0152","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0153","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03778-8","article-title":"Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0154","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac082","article-title":"Establishing antimicrobial susceptibility testing methods and clinical breakpoints for inhaled antibiotic therapy","volume":"9","author":"Ekkelenkamp","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.lpm.2023.104174_bib0155","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 65","key":"10.1016\/j.lpm.2023.104174_bib0156","article-title":"RCT abstract - the efficacy and safety of colistimethate sodium delivered via the I-neb in bronchiectasis: the PROMIS-I randomized controlled trial","volume":"58","author":"Haworth","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0157","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0158","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"Aksamit","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0159","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials","volume":"7","author":"Haworth","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0160","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00110-2020","article-title":"Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies","volume":"56","author":"Chalmers","year":"2020","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.lpm.2023.104174_bib0161","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0162","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","volume":"200","author":"Sibila","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0163","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01451-2020","article-title":"Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa- infected bronchiectasis patients: iBEST study","volume":"57","author":"Loebinger","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2023.104174_bib0164","doi-asserted-by":"crossref","unstructured":"Terpstra L.C., Altenburg J., Bronsveld I., De Kruif M.D., Berk Y., Snijders D., et al. Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. 2020 [cited 2023 Mar 29]; Available from: https:\/\/doi.org\/10.1186\/s12931-022-02243-y","DOI":"10.1183\/13993003.congress-2020.4134"},{"issue":"10","key":"10.1016\/j.lpm.2023.104174_bib0165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"Laska","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0166","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1183\/09031936.00018414","article-title":"Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review","volume":"44","author":"Brodt","year":"2014","journal-title":"Eur Respir J"},{"issue":"14","key":"10.1016\/j.lpm.2023.104174_bib0167","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","article-title":"Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: from bench to bedside. A narrative review","volume":"82","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0168","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0169","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00453-2020","article-title":"Blood eosinophils predict inhaled fluticasone response in bronchiectasis","volume":"56","author":"Aliberti","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0170","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02210-2020","article-title":"Blood eosinophils do not predict inhaled budesonide response in bronchiectasis","volume":"56","author":"Aliberti","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0171","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-021-01646-3","article-title":"Rationale and clinical use of bronchodilators in adults with bronchiectasis","volume":"82","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.lpm.2023.104174_bib0172","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2023.04.029","article-title":"The U-shaped relationship between eosinophil count and bronchiectasis severity: the effect of inhaled corticosteroids","author":"Mart\u00ednez-Garc\u00eda","year":"2023","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0173","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.3390\/ijms19124090","article-title":"How glucocorticoids affect the neutrophil life","volume":"19","author":"Ronchetti","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"507","key":"10.1016\/j.lpm.2023.104174_bib0174","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav3879","article-title":"Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease","volume":"11","author":"Singanayagam","year":"2019","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.lpm.2023.104174_bib0175","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1164\/rccm.202102-0289OC","article-title":"Effects of inhaled corticosteroid\/long-acting \u03b22-agonist combination on the airway microbiome of patients with chronic obstructive pulmonary disease: a randomized controlled clinical trial (DISARM)","volume":"204","author":"Leitao Filho","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.lpm.2023.104174_bib0176","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1159\/000525980","article-title":"Inhaled corticosteroids and mycobacterial infection in patients with chronic airway diseases: a systematic review and meta-analysis","volume":"101","author":"You","year":"2022","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0177","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00037-2017","article-title":"The risk of mycobacterial infections associated with inhaled corticosteroid use","volume":"50","author":"Brode","year":"2017","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.lpm.2023.104174_bib0178","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cpdd.1094","article-title":"Safety, tolerability, and pharmacokinetic evaluation of single and multiple doses of the dipeptidyl peptidase 1 inhibitor brensocatib in healthy Japanese and white adults","volume":"11","author":"Usansky","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0179","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.chest.2018.10.027","article-title":"Bronchiectasis","volume":"155","author":"McShane","year":"2019","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-2600(14)70050-5","article-title":"Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial","volume":"2","author":"Mandal","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0181","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.chest.2017.05.017","article-title":"A randomized controlled trial of atorvastatin in patients with bronchiectasis infected with pseudomonas aeruginosa: a proof of concept study","volume":"152","author":"Bedi","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0182","article-title":"Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis","volume":"2016","author":"Pizzutto","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0183","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1164\/ajrccm\/145.3.548","article-title":"Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis","volume":"145","author":"Tamaoki","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0184","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4046\/trd.2021.0051","article-title":"Efficacy of Roflumilast in bronchiectasis patients with frequent exacerbations: a double-blinded, randomized, placebo-controlled pilot clinical trial","volume":"85","author":"Juthong","year":"2021","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.lpm.2023.104174_bib0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.518345","article-title":"Phosphodiesterase-4 inhibitors for non-COPD respiratory diseases","volume":"12","author":"Kawamatawong","year":"2021","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0186","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1183\/13993003.00148-2015","article-title":"A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis","volume":"46","author":"De Soyza","year":"2015","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0187","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rmed.2012.12.009","article-title":"Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis","volume":"107","author":"Stockley","year":"2013","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0189","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.arbres.2019.12.021","article-title":"RIBRON: the Spanish online bronchiectasis registry. characterization of the first 1912 patients","volume":"57","author":"Martinez-Garc\u00eda","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.lpm.2023.104174_bib0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00408-023-00600-2","article-title":"Bronchodilators in bronchiectasis: we urgently need more trials","volume":"201","author":"\u00c1ngel Mart\u00ednez-Garc\u00eda","year":"2023","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.lpm.2023.104174_bib0191","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1378\/chest.11-0180","article-title":"Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis","volume":"141","author":"Mart\u00ednez-Garc\u00eda","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0192","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02184-2021","article-title":"Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial","volume":"59","author":"Jayaram","year":"2022","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0193","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00408-023-00597-8","article-title":"Tiotropium in patients with bronchiectasis: a prospective cohort study","volume":"201","author":"Shi","year":"2023","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0194","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.2147\/COPD.S115581","article-title":"Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline","volume":"11","author":"Jeong","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"10.1016\/j.lpm.2023.104174_bib0195","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.chest.2018.07.014","article-title":"Characteristics and health-care utilization history of patients with bronchiectasis in US Medicare enrollees with prescription drug plans, 2006 to 2014","volume":"154","author":"Henkle","year":"2018","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0196","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF03256627","article-title":"Changing paradigms in the diagnosis and management of bronchiectasis","volume":"1","author":"Greenstone","year":"2002","journal-title":"Am J Respir Med"},{"issue":"12","key":"10.1016\/j.lpm.2023.104174_bib0197","doi-asserted-by":"crossref","first-page":"766","DOI":"10.14423\/SMJ.0000000000001329","article-title":"Clinical outcomes of noninvasive ventilation in asthma, bronchiectasis, and other COPD","volume":"114","author":"Nemeh","year":"2021","journal-title":"South Med J"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0198","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/crj.12994","article-title":"Temporal trends in survival following ward-based NIV for acute hypercapnic respiratory failure in patients with COPD","volume":"13","author":"Trethewey","year":"2019","journal-title":"Clin Respir J"},{"issue":"5","key":"10.1016\/j.lpm.2023.104174_bib0199","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/ijccm.IJCCM_474_17","article-title":"Noninvasive ventilation for acute respiratory failure due to noncystic fibrosis bronchiectasis","volume":"22","author":"Hadda","year":"2018","journal-title":"Indian J Crit Care Med"},{"issue":"10","key":"10.1016\/j.lpm.2023.104174_bib0200","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.21037\/jtd-21-879","article-title":"Surgical treatment of non-cystic fibrosis bronchiectasis in Central Europe","volume":"13","author":"Selman","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.lpm.2023.104174_bib0201","doi-asserted-by":"crossref","DOI":"10.1038\/srep17382","article-title":"Efficiency and safety of surgical intervention to patients with Non-Cystic Fibrosis bronchiectasis: a meta-analysis","volume":"5","author":"Fan","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.lpm.2023.104174_bib0202","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jtcvs.2016.12.004","article-title":"Surgery for predominant lesion in nonlocalized bronchiectasis","volume":"153","author":"Dai","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.athoracsur.2010.08.035","article-title":"Video-assisted thoracic surgery for bronchiectasis","volume":"91","author":"Zhang","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0204","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/icvts\/ivab329","article-title":"In patients with localized bronchiectasis, does thoracoscopic lung resection result in improved clinical outcomes compared to open surgery?","volume":"34","author":"Kamal","year":"2022","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0205","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-022-02198-2","article-title":"Bronchial artery embolization for the management of frequent hemoptysis caused by bronchiectasis","volume":"22","author":"Lu","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0206","doi-asserted-by":"crossref","DOI":"10.1007\/s00270-023-03361-w","article-title":"Comparison of bronchial artery embolisation versus conservative treatment for bronchiectasis-related nonmassive haemoptysis: a single-centre retrospective study","volume":"46","author":"Yan","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"10.1016\/j.lpm.2023.104174_bib0207","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0208","doi-asserted-by":"crossref","first-page":"88","DOI":"10.21470\/1678-9741-2021-0182","article-title":"The use of intraoperative extracorporeal membrane oxygenation in lung transplantation: initial institutional experience","volume":"38","author":"Erk\u0131l\u0131n\u00e7","year":"2023","journal-title":"Braz J Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0209","article-title":"Double lung transplantation bridged with direct central ambulatory veno-arterial extracorporeal membrane oxygenation in a pulmonary hypertension patient with extreme mediastinal shift","volume":"14","author":"Lodhi","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.lpm.2023.104174_bib0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arbres.2022.12.008","article-title":"Biologics in bronchiectasis: a future treatment?","volume":"59","author":"Nigro","year":"2023","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"10.1016\/j.lpm.2023.104174_bib0211","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccm.2021.12.005","article-title":"Future directions in bronchiectasis research","volume":"43","author":"Amaro","year":"2022","journal-title":"Clin Chest Med"},{"issue":"7","key":"10.1016\/j.lpm.2023.104174_bib0212","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5588\/ijtld.22.0185","article-title":"Bronchiectasis exacerbations: certainties and future challenges","volume":"26","author":"De","year":"2022","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:10:25Z","timestamp":1760105425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498223000118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":211,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0755498223000118"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104174","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104174"}}